A new trading day began on Monday, with SELLAS Life Sciences Group Inc (NASDAQ: SLS) stock price up 4.52% from the previous day of trading, before settling in for the closing price of $1.77. SLS’s price has ranged from $0.77 to $2.27 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 45.94% over the past five years. Meanwhile, its annual earnings per share averaged 36.67%. With a float of $97.67 million, this company’s outstanding shares have now reached $99.78 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SELLAS Life Sciences Group Inc is 2.11%, while institutional ownership is 14.46%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 36.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.28% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Here are SELLAS Life Sciences Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
SELLAS Life Sciences Group Inc (NASDAQ: SLS) saw its 5-day average volume 4.33 million, a positive change from its year-to-date volume of 2.68 million. As of the previous 9 days, the stock’s Stochastic %D was 16.83%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 68.23%, which indicates a significant increase from 17.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1531 in the past 14 days, which was higher than the 0.1196 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7689, while its 200-day Moving Average is $1.3351.
